Fabiana Perrone

7PUBLICATIONS
47CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2026
Liquid Biopsy Monitoring in <i>BRAF</i> V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020).

|May 04, 2026
Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to <i>KRAS</i> status: An Italian real-world study.

|Dec 13, 2024
Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC.

Giulia Mazzaschi, Cristina Marrocchio, Lucas Moron Dalla Tor

|Jul 05, 2024
Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach.

Francesca Di Pressa, Fabiana Perrone, Anna Benini

|Jun 13, 2024
Multiple targets, germline <i>BRCA1</i> mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making.

Fabiana Perrone, Francesco Facchinetti, Benedetta Pellegrino

|Apr 23, 2022
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring <i>BRAF</i> Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups.

Fabiana Perrone, Giulia Mazzaschi, Roberta Minari

Pageof 2

Frequent Collaborators

4 joint publications

Alessandro Leonetti

3 joint publications

Roberta Minari

3 joint publications

Marcello Tiseo

2 joint publications

Sebastiano Buti